 |
인쇄하기
취소
|
Hanmi’s Amodipin touted as innovation product
Hanmi Pharm’s Amodipin (amlodipine camsylate), was recognized as one of 14 innovation products in Korea, according to a report released by the Samsung Economic Research Institute.
The institute said the successful development of Amodipin was chiefly attributed to Hanmi CEO’s direct involvement in the decision-making process and devotion of a dream team with people highly passionate about th...
The institute said the successful development of Amodipin was chiefly attributed to Hanmi CEO’s direct involvement in the decision-making process and devotion of a dream team with people highly passionate about th...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.